Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02864641
Other study ID # 2R44DP003101 CKD
Secondary ID
Status Completed
Phase Phase 2
First received August 1, 2016
Last updated August 9, 2016
Start date July 2015
Est. completion date June 2016

Study information

Verified date August 2016
Source 3-C Institute for Social Development
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this project is to test the efficacy of Planet K, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet K mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in adolescents and young adults with chronic kidney disease (CKD).


Description:

Advances in medical treatment options over the past several decades have translated into substantially higher survival rates for those who suffer with chronic illness. Consequently, the prevalence of chronic illness has risen significantly in recent years, such that one out of every four youth in the United States currently lives with a chronic illness. The health and well-being of these youth is directly impacted by the degree to which they adhere to their treatment regimen. However, treatment regimens for chronic illness can be highly complex, making adherence problematic, particularly when combined with deficits in memory and executive functioning concomitant with many chronic illnesses. Adherence also tends to deteriorate over time; the youth's motivation or commitment to treatment may decline as symptoms improve or negative side effects occur. With low adherence comes worsening symptoms and significantly greater risk for serious medical complications and mortality in young adulthood. The costs associated with low adherence, such as the need for additional care, are also substantial both for the patient and society.

While a number of factors have been found to impact treatment adherence, risk for non-adherence—across varied forms of chronic illness—is markedly elevated when the youth lacks disease- and treatment-related knowledge and when parents provide little supervision for carrying out regimen tasks. With nearly 90% of youth with chronic illness expected to survive and therefore transition from pediatric care into adult-focused healthcare systems, it is critically important to empower youth to take ownership of their own healthcare. To do so, tools there is a need to provide accessible, affordable tools that can effectively increase patients' skills and knowledge for managing their illness and support on-going adherence to their treatment regimen.

The purpose of this project is to test the efficacy of Planet K, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet K mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in adolescents and young adults with chronic kidney disease (CKD).

All participants will complete study measures at pre- and post-assessment time points. In total, participants will take part in this study for approximately 2 months from pre- to post-assessment. Families will be recruited to participate in either the treatment condition or the control group. Families in the treatment condition will receive the Planet K app and access to the associated website for the full duration of the study (4 months) between pre-test and post-test. Families in the control group will not receive access to the app and website but instead will be asked to complete a series of online questionnaires at each of the two data collection time points (pre-test, post-test).

Investigators hypothesize that greater use (i.e., dosage) and prolonged use of Planet K will: increase disease-related knowledge, treatment adherence, self-efficacy for management of CKD, current CKD self-management behaviors, perceived severity of CKD, readiness to transition to independent self-care, and perceived benefits of CKD treatment, while also decreasing perceived barriers to CKD treatment. Moreover, investigators believe that improvement of these outcomes through use of Planet K will result in more positive mental health outcomes for participants, including lower depression and higher reported quality of life. Investigators expect that those in the treatment condition will have better outcomes than those in the control group on all of these measures at both midpoint and post-assessment time points. Finally, investigators expect all participants to report high usability, quality, and value of the Planet K mobile app and website and to positively rate their experience with Planet K.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 21 Years
Eligibility Inclusion Criteria:

- Chronic Kidney Disease diagnosis

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Behavioral:
Planet K
Planet K is a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops.

Locations

Country Name City State
United States 3-C Institute for Social Development Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
3-C Institute for Social Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Knowledge of CKD Both parents and adolescent participants will complete a consultant-created 25 item questionnaire to assess their knowledge of CKD. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Primary End Stage Renal Disease-Adherence Questionnaire (ESRD-AQ) Both adolescent and parent participants will complete a modified version of the End Stage Renal Disease-Adherence Questionnaire (ESRD-AQ; Kim, Y., Evangelista, L.S., Phillips, L.R., Pavlish, C., & Kopple, J.D., 2010). This 28-item measure assesses the extent to which youth adhere to the treatment plan put forth by their healthcare provider, including regular visits to the doctor, taking medications as prescribed, and following dietary recommendations. The parent version contains 22 items and the youth version contains 25 items. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Primary Perceived Treatment Benefits Both adolescents and their parents will report on their perceptions of the benefits and barriers of adherence to the condition treatment regimen. This measure was adapted from the Beliefs about Dietary Compliance scale (BDCS; Bennett et al, 2001) and contains 9 items on both the parent and youth versions. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Primary STARx Transition Readiness Questionnaire This 18-item measure assesses the extent to which youth are ready to transition to independent care and manage their health-related needs independently. Items assess adolescents' independence in scheduling doctor's appointments, remembering to take medication, finding answers to health-related questions, knowledge of their condition, and how easy/difficult these tasks are for the youth. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Secondary Chronic Kidney Disease Self-Efficacy Instrument Adolescents will complete the 25-item Chronic Kidney Disease Self-Efficacy Instrument (CKD-SE; Lin, C., Wu, C., Anderson, R., et al., 2012). This measure assesses patients' self-confidence in managing their condition, including self-confidence in (a) managing the disease autonomously, (b) integrating treatment requirements to fit new situations or social activities, (c) finding solutions to CKD-related problems, and (d) finding social support when needing help. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Secondary Self-Management:Self-Efficacy for Managing Chronic Disease Scale Self-Efficacy for Managing Chronic Disease scale (Ritter & Lorig, 2015), a 6-item measure assessing confidence in self-management ability. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Secondary Self-Management: Partners in Health Scale Partners in Health scale (Cordova et al. 2013), an eleven item measure assessing ability to observe and manage symptoms. Collected at two time points: pre-test and 2 months later at study completion to measure change No
Secondary Quality of Life Adolescents will complete a subset of 19 items from the Kidney Disease and Quality of Life-Short Form (KDQOL-SF; Hays et al., 1997). Items were modified to be more general and applicable to any medical condition. These items comprise subscales that assess patients' symptoms, burden of condition in interfering with life, cognitive functioning, social support, and difficulty sleeping. Collected at two time points: pre-test and 2 months later at study completion to measure change No
See also
  Status Clinical Trial Phase
Terminated NCT05056727 - A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia Phase 3
Withdrawn NCT01655186 - A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus Phase 2
Completed NCT03481686 - Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections N/A
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Enrolling by invitation NCT02237534 - Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia Phase 4
Completed NCT02126293 - Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant Phase 3
Terminated NCT01533545 - Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients N/A
Completed NCT03280615 - Omega 3 Fatty Acids in Patients With Chronic Renal Disease Phase 3
Completed NCT04498156 - Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
Recruiting NCT04020328 - Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency Phase 4
Recruiting NCT06366529 - Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
Active, not recruiting NCT04876963 - HOLT-ED: Holter-monitoring in End-stage Renal Disease
Completed NCT03836508 - Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis N/A
Completed NCT03250715 - Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure N/A
Completed NCT03577249 - Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation Phase 2/Phase 3
Completed NCT01975818 - Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 Phase 2
Active, not recruiting NCT05766644 - App-based Education Program for CKD N/A
Active, not recruiting NCT02791880 - Acute Kidney Injury Genomics and Biomarkers in TAVR Study
Recruiting NCT02947750 - Neurovascular Transduction During Exercise in Chronic Kidney Disease Phase 2
Terminated NCT02286258 - Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) Phase 1/Phase 2